| |
| |
|
| Insider
Information: |
Martin Tami Tillotson |
| Relationship: |
Sr. V.P., Regulatory A... |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
86,933 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,614,075 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
86,933 |
|
|
| Total
Value |
$2,614,075 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -6.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Supernus Pharmaceuticals Inc |
SUPN |
Sr. V.P., Regulatory A... |
2024-02-23 |
86,933 |
2012-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2024-02-23 |
4 |
D |
$29.06 |
$14,094 |
D/D |
(485) |
86,933 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
87,418 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2024-02-22 |
4 |
D |
$27.94 |
$6,873 |
D/D |
(246) |
86,168 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2024-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
750 |
86,414 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2024-01-10 |
4 |
OE |
$9.24 |
$73,920 |
D/D |
8,000 |
93,664 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2024-01-10 |
4 |
AS |
$27.91 |
$223,280 |
D/D |
(8,000) |
85,664 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2023-08-25 |
4 |
S |
$31.59 |
$162,215 |
D/D |
(5,135) |
85,249 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2023-02-22 |
4/A |
D |
$38.57 |
$11,147 |
D/D |
(289) |
90,034 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2023-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
750 |
90,323 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
88,720 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2022-08-22 |
4 |
AS |
$35.98 |
$179,900 |
D/D |
(5,000) |
87,220 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2022-08-22 |
4 |
OE |
$7.90 |
$39,500 |
D/D |
5,000 |
92,220 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2022-08-04 |
4 |
AS |
$32.98 |
$164,900 |
D/D |
(5,000) |
87,220 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2022-08-04 |
4 |
OE |
$7.90 |
$39,500 |
D/D |
5,000 |
92,220 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2021-04-14 |
4 |
OE |
$12.98 |
$40,563 |
D/D |
3,125 |
89,451 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2021-04-14 |
4 |
AS |
$31.98 |
$99,938 |
D/D |
(3,125) |
86,326 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2021-04-13 |
4 |
AS |
$29.98 |
$93,702 |
D/D |
(3,125) |
86,326 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. V.P., Regulatory Affairs |
• – – |
2021-04-13 |
4 |
OE |
$12.98 |
$40,563 |
D/D |
3,125 |
89,451 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP of Regulatory Affairs |
• – – |
2012-12-12 |
4 |
OE |
$1.60 |
$88,200 |
D/D |
48,125 |
50,625 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP of Regulatory Affairs |
• – – |
2012-05-04 |
4 |
B |
$5.00 |
$12,500 |
D/D |
2,500 |
2,500 |
2.74 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
